Drreddys Laboratories | RDY - Ebitda


Drreddys Laboratories reported INR21.59B in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
ANI Pharmaceuticals USD 59.6M 5.52M Sep/2025
Aurora Cannabis CAD 15.37M 26.8M Sep/2025
Bayer EUR 1.51B 1.28B Sep/2025
Canopy Growth CAD 16.62M 38.45M Sep/2025
Cipla INR 12.55B 6.4B Dec/2025
Corcept Therapeutics USD 27.14M 23.27M Jun/2025
Drreddys Laboratories INR 21.59B 1.49B Dec/2025
GlaxoSmithKline GBP 3.18B 45M Jun/2025
Hikma Pharmaceutical USD 369M 84M Dec/2024
Lonza CHF 1.01B 54M Dec/2025
Novartis USD 5.88B 290M Sep/2025
Pacira USD 49.36M 4.96M Sep/2025
Prestige Brands USD 86.83M 7.19M Sep/2025
Richter Gedeon HUF 75.72B 6.71B Sep/2024
Sun Pharmaceuticals INR 49.48B 8.52B Dec/2025
Supernus Pharmaceuticals USD 41.9M 432K Sep/2025
Teva Pharmaceutical Industries USD 1.64B 243M Dec/2025